217 related articles for article (PubMed ID: 19805648)
1. Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury.
Oshima Y; Ouchi N; Shimano M; Pimentel DR; Papanicolaou KN; Panse KD; Tsuchida K; Lara-Pezzi E; Lee SJ; Walsh K
Circulation; 2009 Oct; 120(16):1606-15. PubMed ID: 19805648
[TBL] [Abstract][Full Text] [Related]
2. Regulation and actions of activin A and follistatin in myocardial ischaemia-reperfusion injury.
Chen Y; Rothnie C; Spring D; Verrier E; Venardos K; Kaye D; Phillips DJ; Hedger MP; Smith JA
Cytokine; 2014 Oct; 69(2):255-62. PubMed ID: 25052838
[TBL] [Abstract][Full Text] [Related]
3. Activin type II receptor signaling in cardiac aging and heart failure.
Roh JD; Hobson R; Chaudhari V; Quintero P; Yeri A; Benson M; Xiao C; Zlotoff D; Bezzerides V; Houstis N; Platt C; Damilano F; Lindman BR; Elmariah S; Biersmith M; Lee SJ; Seidman CE; Seidman JG; Gerszten RE; Lach-Trifilieff E; Glass DJ; Rosenzweig A
Sci Transl Med; 2019 Mar; 11(482):. PubMed ID: 30842316
[TBL] [Abstract][Full Text] [Related]
4. Cardiac myocyte-specific ablation of follistatin-like 3 attenuates stress-induced myocardial hypertrophy.
Shimano M; Ouchi N; Nakamura K; Oshima Y; Higuchi A; Pimentel DR; Panse KD; Lara-Pezzi E; Lee SJ; Sam F; Walsh K
J Biol Chem; 2011 Mar; 286(11):9840-8. PubMed ID: 21245136
[TBL] [Abstract][Full Text] [Related]
5. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins.
Sidis Y; Mukherjee A; Keutmann H; Delbaere A; Sadatsuki M; Schneyer A
Endocrinology; 2006 Jul; 147(7):3586-97. PubMed ID: 16627583
[TBL] [Abstract][Full Text] [Related]
6. Heparin and activin-binding determinants in follistatin and FSTL3.
Sidis Y; Schneyer AL; Keutmann HT
Endocrinology; 2005 Jan; 146(1):130-6. PubMed ID: 15471966
[TBL] [Abstract][Full Text] [Related]
7. Follistatin-like 3, an activin A binding protein, is involved in early pregnancy loss.
Xu Y; Xie J; Wan L; Wang M; Xu Y; Wang H; Dong M
Biomed Pharmacother; 2020 Jan; 121():109577. PubMed ID: 31810141
[TBL] [Abstract][Full Text] [Related]
8. MiR-29a in mesenchymal stem cells inhibits FSTL1 secretion and promotes cardiac myocyte apoptosis in hypoxia-reoxygenation injury.
Li KS; Jiang WP; Li QC; Zhang HW; Bai Y; Zhang X; Li HY
Cardiovasc Pathol; 2020; 46():107180. PubMed ID: 31945680
[TBL] [Abstract][Full Text] [Related]
9. Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes.
Panse KD; Felkin LE; López-Olañeta MM; Gómez-Salinero J; Villalba M; Muñoz L; Nakamura K; Shimano M; Walsh K; Barton PJ; Rosenthal N; Lara-Pezzi E
J Cardiovasc Transl Res; 2012 Dec; 5(6):814-26. PubMed ID: 22915069
[TBL] [Abstract][Full Text] [Related]
10. Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart.
Oshima Y; Ouchi N; Sato K; Izumiya Y; Pimentel DR; Walsh K
Circulation; 2008 Jun; 117(24):3099-108. PubMed ID: 18519848
[TBL] [Abstract][Full Text] [Related]
11. Effects of the Activin A-Follistatin System on Myocardial Cell Apoptosis through the Endoplasmic Reticulum Stress Pathway in Heart Failure.
Liu M; Mao C; Li J; Han F; Yang P
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208629
[TBL] [Abstract][Full Text] [Related]
12. Follistatin and follistatin like-3 differentially regulate adiposity and glucose homeostasis.
Brown ML; Bonomi L; Ungerleider N; Zina J; Kimura F; Mukherjee A; Sidis Y; Schneyer A
Obesity (Silver Spring); 2011 Oct; 19(10):1940-9. PubMed ID: 21546932
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of follistatin-like 3 in gonads causes defects in gonadal development and function in transgenic mice.
Xia Y; Sidis Y; Schneyer A
Mol Endocrinol; 2004 Apr; 18(4):979-94. PubMed ID: 14739256
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of bleomycin-induced pulmonary fibrosis by follistatin.
Aoki F; Kurabayashi M; Hasegawa Y; Kojima I
Am J Respir Crit Care Med; 2005 Sep; 172(6):713-20. PubMed ID: 15976370
[TBL] [Abstract][Full Text] [Related]
15. Growth differentiation factor 9 (GDF9) suppresses follistatin and follistatin-like 3 production in human granulosa-lutein cells.
Shi FT; Cheung AP; Huang HF; Leung PC
PLoS One; 2011; 6(8):e22866. PubMed ID: 21829661
[TBL] [Abstract][Full Text] [Related]
16. Protective role of cardiac CFTR activation upon early reperfusion against myocardial infarction.
Uramoto H; Okada T; Okada Y
Cell Physiol Biochem; 2012; 30(4):1023-38. PubMed ID: 23221371
[TBL] [Abstract][Full Text] [Related]
17. Activin Enhances α- to β-Cell Transdifferentiation as a Source For β-Cells In Male FSTL3 Knockout Mice.
Brown ML; Andrzejewski D; Burnside A; Schneyer AL
Endocrinology; 2016 Mar; 157(3):1043-54. PubMed ID: 26727106
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial LonP1 protects cardiomyocytes from ischemia/reperfusion injury in vivo.
Venkatesh S; Li M; Saito T; Tong M; Rashed E; Mareedu S; Zhai P; Bárcena C; López-Otín C; Yehia G; Sadoshima J; Suzuki CK
J Mol Cell Cardiol; 2019 Mar; 128():38-50. PubMed ID: 30625302
[TBL] [Abstract][Full Text] [Related]
19. Globular adiponectin attenuates myocardial ischemia/reperfusion injury by upregulating endoplasmic reticulum Ca²⁺-ATPase activity and inhibiting endoplasmic reticulum stress.
Guo J; Bian Y; Bai R; Li H; Fu M; Xiao C
J Cardiovasc Pharmacol; 2013 Aug; 62(2):143-53. PubMed ID: 23609327
[TBL] [Abstract][Full Text] [Related]
20. The structure of FSTL3.activin A complex. Differential binding of N-terminal domains influences follistatin-type antagonist specificity.
Stamler R; Keutmann HT; Sidis Y; Kattamuri C; Schneyer A; Thompson TB
J Biol Chem; 2008 Nov; 283(47):32831-8. PubMed ID: 18768470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
